• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Psychosocial barriers may hinder expanded buprenorphine access amongst opioid use disorder patients

byNancy LuandAvneesh Bhangu
February 4, 2022
in Chronic Disease, Psychiatry, Wellness
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this study, counselors reported that patients would be more likely to access buprenorphine treatment if they had access to greater social resources, such as housing or internet.

2. Counselors also report that increased screening at intake about psychosocial factors would be helpful.

Evidence Rating Level: 3 (Average)

One of the current national public health priorities is expanding access to treatment for people with opioid use disorder (OUD), which includes buprenorphine treatment. Though some research has been performed on improving access to initial buprenorphine treatment in the emergency department setting, it remains difficult to retain such patients for long-term care. Barriers to retention and treatment adherence are still poorly understood.

This study was a survey of addiction counselors (n=27) at the Denver Health’s Outpatient Behavioral Health Services clinic, which served approximately 900 patients at the time of study. Only counselors involved in OUD treatment were included. All clinic counselors received an invitation to complete a survey, and 25 of the 27 eligible counselors responded. There was no missing data. Counselors were asked about various patient attributes associated with difficulty engaging with treatment (for example, housing assistance, access to phone, transportation access, etc.) as well as the most helpful services for these patients.

Results showed a large majority (84%) of counselors noted that housing assistance was necessary. Additionally, factors such as residential treatment placement, mental health care, and access to a phone were deemed important to the counselors. They also noted that having a dedicated case manager for each patient would be helpful. This study did have several limitations, especially its focus on one clinic in an urban setting, which may not be generalizable. Nonetheless, this study was significant in suggesting there are many perceived barriers that may be currently impeding access to buprenorphine treatment for those with OUD.

Click to read the study in Journal of Addiction Medicine

RELATED REPORTS

Spectrophotometric assays for methadone may be effective for diversion control

Telemedicine bridge clinics may be helpful for opioid use disorder treatment

Wellness Check: Addictions

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

 

 

 

 

 

 

Tags: addictionbuprenorphineopioidOUDpsychosocial
Previous Post

#VisualAbstract: Daratumumab-based therapies were associated with higher rates of sustained minimal residual disease negativity in patients with newly diagnosed multiple myeloma

Next Post

#VisualAbstract: Skin cancer risk factors and screening differ among Asian American individuals

RelatedReports

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Wellness

Spectrophotometric assays for methadone may be effective for diversion control

April 26, 2022
No obesity paradox found between BMI, stroke, and death
Chronic Disease

Telemedicine bridge clinics may be helpful for opioid use disorder treatment

April 25, 2022
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Wellness

Wellness Check: Addictions

April 21, 2022
Patients with low back pain or pain at multiple sites at highest risk for chronic opioid use
Chronic Disease

Changes in opioid or nonopioid pain treatments not attributable to state opioid prescribing laws

March 30, 2022
Next Post
#VisualAbstract: Skin cancer risk factors and screening differ among Asian American individuals

#VisualAbstract: Skin cancer risk factors and screening differ among Asian American individuals

Novel coronavirus identified from patients with pneumonia in Wuhan, China

2 Minute Medicine Rewind February 7, 2022

Association between age at onset of multimorbidity and incidence of dementia:

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.